Molecular Epidemiology of HIV-1 in Ghana: Subtype Distribution, Drug Resistance and Coreceptor Usage
- Simon Fraser Univ., Burnaby, BC (Canada); British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC (Canada)
- British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC (Canada)
- Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
- Korle Bu Teaching Hospital, Accra (Ghana)
- University of Ghana, Accra (Ghana)
- British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC (Canada); Univ. of British Columbia, Vancouver, BC (Canada)
The greatest HIV-1 genetic diversity is found in West/Central Africa due to the pandemic’s origins in this region, but this diversity remains understudied. We characterized HIV-1 subtype diversity (from both sub-genomic and full-genome viral sequences), drug resistance and coreceptor usage in 103 predominantly (90%) antiretroviral-naive individuals living with HIV-1 in Ghana. Full-genome HIV-1 subtyping confirmed the circulating recombinant form CRF02_AG as the dominant (53.9%) subtype in the region, with the complex recombinant 06_cpx (4%) present as well. Unique recombinants, most of which were mosaics containing CRF02_AG and/or 06_cpx, made up 37% of sequences, while “pure” subtypes were rare (<6%). Pretreatment resistance to at least one drug class was observed in 17% of the cohort, with NNRTI resistance being the most common (12%) and INSTI resistance being relatively rare (2%). CXCR4-using HIV-1 sequences were identified in 23% of participants. Overall, our findings advance our understanding of HIV-1 molecular epidemiology in Ghana. Extensive HIV-1 genetic diversity in the region appears to be fueling the ongoing creation of novel recombinants, the majority CRF02_AG-containing, in the region. The relatively high prevalence of pretreatment NNRTI resistance but low prevalence of INSTI resistance supports the use of INSTI-based first-line regimens in Ghana.
- Research Organization:
- Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
- Sponsoring Organization:
- Canadian Institutes for Health Research; Rideau Hall Foundation (RHF); USDOE
- Grant/Contract Number:
- 89233218CNA000001
- OSTI ID:
- 1908490
- Report Number(s):
- LA-UR-22-32691
- Journal Information:
- Viruses, Journal Name: Viruses Journal Issue: 1 Vol. 15; ISSN 1999-4915
- Publisher:
- MDPICopyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
Rare HIV-1 Subtype J Genomes and a New H/U/CRF02_AG Recombinant Genome Suggests an Ancient Origin of HIV-1 in Angola
HIV drug resistance during antiretroviral therapy scale-up in Uganda, 2012–19: a population-based, longitudinal study
HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form
Journal Article
·
Sun Jul 31 20:00:00 EDT 2016
· AIDS Research and Human Retroviruses
·
OSTI ID:1459811
HIV drug resistance during antiretroviral therapy scale-up in Uganda, 2012–19: a population-based, longitudinal study
Journal Article
·
Fri Dec 26 19:00:00 EST 2025
· The Lancet Microbe
·
OSTI ID:3007520
HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form
Journal Article
·
Fri Oct 08 20:00:00 EDT 2010
· Retrovirology
·
OSTI ID:1626608